HKEX Insider Activity — 2026-10-20

by hk-insider-activities-daily

🇭🇰 HKEX DI Report — 2026-10-20

🆕 NEW ENTRY — 3816 KFM Kingdom Holdings ← Luxshare Precision Limited, 57.00% (increased by 57.00pp from prior filing), bought 342,000,000 shares @ HKD 2.00 for HK$684.0M total Read: This is a controlling-stake acquisition by a strategic buyer, not a passive fund position, though the event date of 2026-09-13 means the filing is a month old.

🆕 NEW ENTRY — 2636 Shenzhen Transsion Holdings (H) ← The Capital Group Companies, 7.69% (increased by 7.69pp from prior filing), bought 6,665,400 shares @ HKD 35.30 for HK$235.3M total Read: A long-only global manager building straight to 7.7% is the largest conviction-style entry in this batch.

🆕 NEW ENTRY — 2359 WuXi AppTec (H) ← FIL Limited, pooled with 483A Bay Street Holdings LP, 483A Bay Street Holdings Management LLC, Fidelity Canada Investors LLC, Pandanus Associates Inc. and Pandanus Partners L.P., 5.06% (increased by 0.14pp from prior filing), bought 773,900 shares @ HKD 203.74 for HK$157.7M total Read: The six filings report one Fidelity-group position that just crossed 5%, so count it as a single new holder rather than six.

🆕 NEW ENTRY — 9886 Dingdang Health Technology Group ← JPMorgan Chase & Co., 5.72% (increased by 5.65pp from prior filing), bought 70,100,846 shares @ HKD 0.71 for HK$49.8M total Read: A sizeable jump from almost nothing in a sub-HK$1 stock, though JPMorgan's filings often include client and prime-brokerage positions, so the intent is unclear.

🆕 NEW ENTRY — 1276 Jiangsu Hengrui Pharmaceuticals (H) ← Norges Bank, 5.18% (increased by 0.21pp from prior filing), bought 540,800 shares @ HKD 47.87 for HK$25.9M total Read: Norway's sovereign fund is now a disclosable holder of this pharma name, which is a steady long-term institutional endorsement.

🆕 NEW ENTRY — 6613 Lens Technology (H) ← JPMorgan Chase & Co., 5.02% (increased by 0.46pp from prior filing), bought 1,400,833 shares @ HKD 17.97 for HK$25.2M total Read: This is a marginal crossing of the 5% line, so it shows accumulation but not a strong conviction signal.

🆕 NEW ENTRY — 2050 Zhejiang Sanhua Intelligent Controls (H) ← JPMorgan Chase & Co., 5.05% (increased by 0.12pp from prior filing), bought 593,555 shares @ HKD 21.82 for HK$12.95M total Read: A small crossing of the 5% threshold with limited directional weight.

🆕 NEW ENTRY — 3898 Zhuzhou CRRC Times Electric (H) ← FIL Limited, pooled with Pandanus Associates Inc. and Pandanus Partners L.P., 5.00% (increased by 0.04pp from prior filing), bought 214,700 shares @ HKD 28.13 for HK$6.0M total Read: This is one Fidelity-group position sitting right on the 5% line, and it is more a threshold-crossing event than a real buying signal.

🆕 NEW ENTRY — 9927 Seres Group (H) ← BlackRock, Inc., 5.57% (increased by 0.89pp from prior filing) Read: This was filed under reason 1004, but the aggregate position grew, so it reflects a re-allocation across BlackRock entities with a net increase rather than an exit.

🆕 NEW ENTRY — 390 China Railway Group (H) ← BlackRock, Inc., 5.01% (increased by 0.29pp from prior filing) Read: This is a 1004 re-allocation within BlackRock entities, and the holding rose slightly to just above 5%.

🆕 NEW ENTRY — 1357 Meitu, Inc. ← BlackRock, Inc., 5.15% (increased by 0.16pp from prior filing) Read: This is a 1004 re-allocation within BlackRock entities, with a modest net increase and the aggregate still above 5%.

🆕 NEW ENTRY — 1398 Industrial and Commercial Bank of China (H) ← BlackRock, Inc., 5.02% (increased by 0.03pp from prior filing) Read: This is a paperwork-driven 1004 re-allocation with an almost unchanged holding, so it is not a real flow signal.

🆕 NEW ENTRY — 2423 KE Holdings ← JPMorgan Chase & Co., 5.01% (increased by 0.02pp from prior filing), position moved 570,546 shares @ HKD 46.33 for HK$26.4M total Read: This is a 1004 re-allocation with a negligible net increase, and JPMorgan stays just above the 5% line.